INTRODUCTION
============

Nesprins are a novel spectrin-repeat (SR) family of cellular scaffolds and linkers, predominantly known to localize to the nuclear envelope (NE; [@B37]; [@B20]). To date, four nesprin genes have been identified, and their full-length proteins localize to the outer nuclear membrane and provide connections to cytoskeletal filaments. Full-length nesprin-1 and nesprin-2 bind F-actin directly via their N-terminal calponin homology domains ([@B36]). The SRs of nesprin-3 and nesprin-4 interact with plectin and Kif5b in a manner that establishes intermediate filament and microtubule connections, respectively ([@B32]; [@B26]). NE nesprins are one of the major components of the linker of the nucleoskeleton and cytoskeleton (LINC) complex and form connections with inner NE transmembrane SUN domain proteins in the perinuclear space. In turn, the SUN domain proteins interact with the nuclear lamina underlying the inner nuclear membrane to complete the LINC complex ([@B5]). This double membrane--spanning complex maintains nuclear integrity, mediates nuclear anchorage and positioning, and plays a definitive role in mechanosensing and cell migration ([@B25]; [@B1]).

The emergence of KASH-less nesprin isoforms, generated by alternative transcription, has provided evidence for nesprin functionality beyond the NE ([@B24]). Indeed, all the KASH-less nesprin isoforms examined thus far have localized, often in a cell-specific manner, to an array of different cellular compartments, including focal adhesions, the nucleolus, the Golgi, and promyelocytic leukemia bodies, and diffusively in the cytosol and nucleus ([@B16]; [@B31]; [@B22]). Recently we reported the presence of p50^Nesp1^ in mRNA processing bodies (P-bodies, or PBs). p50^Nesp1^ is a short variant of nesprin-1 composed entirely of SRs that facilitates PB anchorage to microtubules and plays a role in PB dynamic properties such as localized movement ([@B23]). Data from this and other studies suggest that miniature nesprin-1 isoforms composed of SRs otherwise located in the central rod region of nesprin-1 giant can localize in the nucleus and cytosol ([@B31]; [@B22], [@B23]).

In this study, we identified potential nesprin-1 interacting partners for KASH-less nesprin-1 variants to further characterize the function of nesprins as intracellular scaffolds and linkers. Mass spectrometry identified a host of proteins associated with nesprin-1 involved in RNA-processing events, including matrin-3 (Matr3). Matr3 is a well-established nuclear matrix protein identified two decades ago ([@B21]). However, its function is only beginning to emerge through the identification of novel binding partners that suggest matr3 functions in a number of key cellular processes, including chromatin remodeling, transcription, RNA splicing, DNA replication and repair, and apoptosis ([@B35]; [@B33]; [@B28]; [@B4]).

Here we report a role for a new potential matr3 isoform in miRNA-mediated translational repression and show for the first time its localization in PBs. By identifying matr3 PB-localizing and PB-binding domains, we suggest cytoplasmic functions for matr3 and speculate that neuronal and muscular degenerative diseases caused by mutations within the matr3 gene could hamper posttranscriptional processes associated with cytoplasmic matr3 RNA-processing events ([@B30]; [@B14]).

RESULTS
=======

Identification of novel nesprin-1 binding partners
--------------------------------------------------

To further characterize the ability of nesprin-1 to function as an intracellular scaffold, we set out to identify novel binding partners for KASH-less nesprin-1 isoforms. Coimmunoprecipitations (co-IPs) with two previously characterized nesprin-1 polyclonal antibodies (pAbN4 and pAbN5) were performed on U2OS whole-cell lysates ([Figure 1A](#F1){ref-type="fig"}). The epitopes for these antibodies are located within SR 49 of the nesprin-1 giant and are separated by several amino acid residues. In U2OS cells, both antibodies only detect PB and nuclear nesprin-1 variants, as previously described ([@B23]).

![Identification of novel nesprin-1 binding partners. (A) Schematic illustrating the location of pAbN4 and pAbN5 relative to the nesprin-1 giant, nesprin-1β, and smaller KASH-less nesprin-1 isoforms. (B) SDS--PAGE and silver-stained gel of pAbN4 and pAbN5 co-IPs. Table summarizes interacting partners identified by mass spectrometry that were present in both nesprin-1 immune complexes but not the IgG control. (C) Validation of mass spectrometry binding partners by co-IPs and Western blotting (*N* = 4). (D) GST pull downs using SRs located in the central rod region of nesprin-1 at bait (*N* = 3).](3894fig1){#F1}

pAbN4, pAbN5, and control immunoglobulin G (IgG) immune complexes from U2OS cells were separated by SDS--PAGE, and silver-stained bands present in both pAbN4 and pAbN5 lanes, but not the negative control IgG lane, were identified by mass spectrometry ([Figure 1B](#F1){ref-type="fig"}). Only proteins detected by both antibodies were considered as potential novel interactors. These included nuclear components involved in RNA processing such as Matr3, PTB-associated splicing factor (PSF), DDx5, and hnRNP A2/B1. Cytoplasmic proteins were also identified (HSP90, 40S ribosomal protein SA, creatine kinase, cytoskeletal actin) as well as Importin-β, suggesting that these KASH-less nesprin-1 variants may function as intracellular nuclear, cytoplasmic, and nuclear envelope scaffolds consistent with their localizations ([@B23]).

Interestingly, no nesprin-1 was detected by mass spectrometry, which may be due to poor detection of nesprin-1 peptides by mass spectrometry or because the bands corresponding to nesprin-1 were not sufficiently excised or digested from the silver-stained gels. To confirm nesprin-1 was being immunoprecipitated by pAbN4 and pAbN5, we performed Western blotting with a previously described nesprin-1 monoclonal antibody (4C11) to show nesprin-1 enrichment within pAbN4 and pAbN5 immune complexes ([@B12]). Indeed, nesprin-1 isoforms p50^Nesp1^, p144^Nesp1^, and nesprin-1β were detected in pAbN4 and pAbN5 IPs. Further Western blotting was performed to confirm the presence of Matr3, PSF, DDx5, and Importin-β ([Figure 1C](#F1){ref-type="fig"}). Although matr3, PSF, and DDx5 coimmunoprecipitated with nesprin-1, Importin-β was also present within the control IgG immune complexes and therefore not considered as a potential nesprin-1 binding protein.

To confirm the interaction between nesprin-1 with matr3, PSF, and DDx5, we performed glutathione *S*-transferase (GST) pull-down experiments using previously described GST-nesprin-1 constructs ([Figure 1D](#F1){ref-type="fig"}). GST-SR1, GST-SR2, GST-SR3, and GST-SR4 represent SRs 48--51 of nesprin-1 giant and are also the four SRs that comprise the p50^Nesp1^ isoform that localizes to PBs. These constructs were selected because they are present in close proximity to the nesprin-1 pAbN4 and pAbN5 epitopes. Interestingly, matr3 and DDx5 associated with SR1 and SR2, respectively, which are the same SRs that we have previously shown to bind miRNA-mediated gene silencing (miRISC) regulators Argonaute-2 (Ago2) and p54/DDx6. PSF did not associate with any of the SRs used in this experiment, suggesting that it likely interacts with another of the many SRs of nesprin-1 ([Figure 1D](#F1){ref-type="fig"}). Together these experiments identify novel nesprin-1 binding partners and potential new functions for nesprin-1.

Matr3 is required for miRISC function
-------------------------------------

SR48 and SR49 (SR1 and SR2 domains in [Figure 1D](#F1){ref-type="fig"}) of nesprin-1, which Matr3 and DDx5 associate with, have previously been shown to be required for miRISC function ([@B23]). Furthermore, matr3 and DDx5 have also previously been identified in Argonaute protein complexes ([@B11]; [@B23]). Together these experiments suggest matr3 and DDx5 may be part of the miRISC complex required for miRNA-mediated gene silencing. We therefore decided to perform the Let-7a miRISC reporter assay to determine whether these two proteins are required for miRNA-mediated gene silencing. The psi-CHECK2-let-7a 3× luciferase vector contains 3×Let-7a miRNA-binding sites, and luciferase expression is translationally repressed when transfected into cells expressing endogenous Let-7a and functional miRISC complexes ([@B18]; [@B15]). Knockdown of core silencing proteins involved in miRISC pathways, for example, Rck/p54, GW182, or p50^Nesp1^, reduces miRISC activity ([@B3]; [@B23]). To determine whether matr3 or DDx5 is also required for this process, we performed the Let-7a miRISC assay in U2OS cells depleted of either DDx5 or matr3 with small interfering RNAs (siRNAs). Rck/p54 knockdown was also performed and served as a positive control for these assays. Successful knockdown of these proteins was determined by Western blotting, with which we observed a ∼75.6% knockdown of matr3, ∼59.6% knockdown of DDx5, and ∼64.9% knockdown of p54 ([Figure 2A](#F2){ref-type="fig"}). Endogenous Let-7a was unable to attenuate luciferase silencing in DDx5-depleted cells; however, matr3 knockdown enhanced luciferase activity comparable to Rck/p54 depletion, suggesting Matr3 is required for miRNA-mediated gene silencing ([Figure 2B](#F2){ref-type="fig"}). When the Let-7a binding sites of the luciferase reporter were mutated so they could no longer associate with endogenous Let-7a, no change in luciferase activity was observed under any of the knockdown conditions ([Figure 2C](#F2){ref-type="fig"}). These data suggest matr3 induces translational repression in a miRNA-mediated manner.

![Matr3 is required for miRISC function. (A) Western blotting demonstrating efficient knockdown of matrin3, DDx5, and p54 using their respective siRNAs (*N* = 4). (B) Cells depleted of Matr3 have attenuated miRISC function of a Let-7a reporter assay. p54 knockdown cells served as a positive control (*N* = 4). (C) Endogenous Let-7a does not suppress activity of the reporter under any knockdown condition when the Let-7a binding sites are mutated (*N* = 4). (C, D) Cells depleted of Matr3 have attenuated miRISC function of CXCR4 reporter assay (*N* = 3). *\**, *p* \< 0.05; *\*\**, *p* \< 0.01; *\*\*\**, *p* \< 0.001; one-way ANOVA, Dunnett's post hoc test.](3894fig2){#F2}

Additionally, we monitored the ability of exogenous CXCR4 miRNA to silence a luciferase reporter containing 6×CXCR4 miRNA binding sites ([@B7]). As with the Let-7a reporter, no change in luciferase activity was seen in DDx5-depleted cells, while matr3- and p54-depleted cells had significantly enhanced luciferase expression ([Figure 2D](#F2){ref-type="fig"}). Together these experiments suggest Matr3 is a novel component of the miRISC complex required for miRNA-mediated gene silencing.

Matr3 localizes to RNA PBs
--------------------------

Matr3 is a 95 kDa nuclear matrix protein containing two RNA-recognition motifs (RRMs) flanked by two zinc finger (ZnF) domains ([Figure 3A](#F3){ref-type="fig"}). The functions of these domains remain unclear; however, matr3 has multifunctional properties in many cellular processes ([@B35]; [@B33]; [@B28]; [@B4]). Therefore we examined the cellular localization of matr3 using antibodies targeting the N-terminal (M3N) or C-terminal (M3C) ends of the protein in U2OS cells ([Figure 3B](#F3){ref-type="fig"}). Both M3N and M3C antibodies stained the nuclear matrix; however, M3N additionally detected cytoplasmic foci that colocalized with the PB marker Hedls ([Figure 3B](#F3){ref-type="fig"}). This suggests that matr3 is present in PBs, which is consistent with its miRISC function.

![Matr3 localizes to PBs. (A) Schematic representation illustrating the structure of matr3 and the location of M3N and M3C antibodies. (B) M3C detects the nuclear matrix in U2OS cells. M3N detects the nuclear matrix and cytoplasmic foci that colocalize with PB markers Hedls (*N* = 100--300 over four experimental repeats).](3894fig3){#F3}

Matr3 interacts with PB proteins
--------------------------------

To identify whether PB protein complexes were associated with matr3, we probed M3N and M3C immune complexes for Ago2, p54, and Dcp1a ([Figure 4A](#F4){ref-type="fig"}). M3C immune complexes did not contain any of the PB proteins, while all 3 PB components were present in M3N immune complexes, of which Ago2 association was RNA dependent. Both M3N and M3C contained PSF, a nuclear matr3 binding partner, and served as a positive control for matr3 isolated protein complexes ([Figure 4A](#F4){ref-type="fig"}; [@B35]).

![Unique matr3 is present within PBs. (A) Co-IPs with M3N and M3C show that only M3N immune complexes contain PB proteins. PSF served as a positive control (*N* = 4). (B) M3N detects two Western bands in U2OS whole-cell lysates. Subcellular fractions show the larger ∼95 kDa band is present in the nuclear fraction, and the smaller ∼50 kDa band is present in the cytosol. Lamin B1 and α-tubulin were used to measure purity of nuclear and cytoplasmic fractions respectively (*N* = 4). (C) PB proteins coimmunoprecipitate with the smaller matr3 variant, while PSF co-IPs with the larger form (*N* = 4). (D) si-M3N knocks down both M3N bands detected by Western blotting, while M3C only knocks down the larger molecular weight band (*N* = 5). (E) si-M3N knocks down cytoplasmic foci and nuclear matr3 staining. si-M3C does not affect PB but does eliminate nuclear staining. Cytoplasmic foci knockdown was determined by cells having \<4 foci (*N* = 400 over four experimental repeats). Nuclear matr3 levels were measured by nuclear matr3 fluorescence integrated density (*N* = 100 over four experiments). *\**, *p* \< 0.05; *\*\*\*\**, *p* \< 0.0001; one-way ANOVA, Dunnett's post hoc test.](3894fig4){#F4}

New matr3 isoform localizes to PBs
----------------------------------

Next we investigated whether nuclear and cytosolic matr3 represents a common pool of the protein by probing U2OS cytosolic and nuclear extracts with antibodies to M3N, lamin B1, and α-tubulin ([Figure 4B](#F4){ref-type="fig"}). The presence of lamin B1 only in the nuclear extract and α-tubulin only in the cytosolic pool suggested pure fractions of the two compartments. Western blotting with M3N detected the 95 kDa matr3 protein in the nucleus, while a smaller ∼50 kDa band was present in the cytosolic fraction ([Figure 4B](#F4){ref-type="fig"}). Probing for M3C detected only the 95 kDa band in the nuclear fraction (unpublished data). These data indicate that two populations of Matr3 are present: a 95 kDa protein in the nucleus and a smaller ∼50 kDa protein in the cytoplasm.

We performed co-IPs to identify which proteins were associated with the two different matr3 species ([Figure 4C](#F4){ref-type="fig"}). Ago2, Rck/p54, and Dcp1a, but not PSF, immune complexes were enriched with the smaller 50 kDa matr3 variant, while PSF coimmunoprecipitated with the larger 95 kDa nuclear matr3 protein. Western blotting of these co-IPs for the three PB proteins and PSF showed no PSF to be present in PB complexes or visa versa (i.e., no PB components in PSF immune complexes; [Figure 4C](#F4){ref-type="fig"}).

To identify whether the 50 kDa band was a novel isoform, splice variant, cleavage product, or a nonspecific protein recognized by the M3N antibody, we used siRNAs created against the N-terminal and C-terminal (si-M3N and si-M3C, respectively) open reading frame of matr3. Western blotting demonstrated si-M3N was able to knock down both the 95 and 50 kDa bands, while si-M3C only knocked down the larger 95 kDa band ([Figure 4D](#F4){ref-type="fig"}). Both siRNAs were able to knock down nuclear matr3 levels, as measured by fluorescence intensity within the nucleus ([Figure 4E](#F4){ref-type="fig"}). Previously, U2OS cells have been established to contain several PBs under basal conditions ([@B23]). Therefore, to determine PB knockdown with the siRNAs, we examined 400 U2OS cells and counted the percentage of cells that had between 0 and 4 PBs. si-M3N--transfected cells had a large population of cells containing fewer than 4 PBs (35 ±7.70%, *n* = 400), while si-M3C--transfected cells had PBs comparable to the control siRNA (si-M3C 75 ±7.62%, and si-control 79.25 ±4.57%, *n* = 400) ([Figure 4E](#F4){ref-type="fig"}). Together these experiments suggest a novel N-terminal matr3 variant exists in PBs that is different from the nuclear matr3 identified to date.

Matr3 ZnF1 and RRM1 are required for PB and SG localization
-----------------------------------------------------------

PB detection with the N-terminal antibody and siRNA knockdown of the ∼50 kDa band with si-M3N suggest that PB matr3 is likely to retain its N-terminal domains, assuming no unusual alternative splicing of matr3 occurs. Therefore, to determine which domains of matr3 were required for PB localization, we created Flag-tagged matr3 C-terminal truncation constructs by introducing stop codons after every major domain of matr3 ([Figure 5A](#F5){ref-type="fig"}). Full-length Flag-matr3, Flag-798, and Flag-567 all showed nuclear matrix localization in U2OS cells. However, removal of the second RRM in Flag-469 induced cytoplasmic foci formation, with some transfected cells also displaying weak nuclear localization. Subsequent truncation of RRM1 in Flag-322 resulted in loss of cytoplasmic foci ([Figure 5A](#F5){ref-type="fig"}).

![Matr3 ZnF1 and RBD1 are required for PB localization. (A) Flag-tagged C-terminal truncation constructs were created and transfected into U2OS cells. The table indicates which constructs had cytoplasmic and nuclear localizations (*N* = 30--50 over three experimental repeats). Flag-469 did have weak nuclear staining in a small population of transfected cells (13.33% of cells). (B) Flag-469 foci formed colocalize with PB marker p54 and induce SG formation, as indicated by PABP-1 staining. After heat shock (42°C, 45 min), Flag-469 moves from PBs to SGs. Colocalization of Flag-469 with p54 PBs and PABP-1 SGs before and after SGs were quantified using Pearson's colocalization coefficient (*N* = 15 over three experimental repeats). (C) GST-469 pulls down Ago2 and p54 from U2OS cell extract (*N* = 3). (D) Flag-469 has reduced interactions with Ago2 and p54 after heat shock. *\**, *p* \< 0.05; *\*\**, *p* \< 0.01; *\*\*\*\**, *p* \< 0.0001; Student's *t* test.](3894fig5){#F5}

The phenotype of cytoplasmic foci induced by Flag-469 appeared to look like a mixture of PBs and stress granules (SGs) at first glance. As matr3 has previously been detected in SGs by mass spectroscopy and in matr3 overexpression studies ([@B10]; [@B13]), we costained Flag-469--transfected cells with the endogenous PB marker p54 and SG marker PABP-1 ([Figure 5B](#F5){ref-type="fig"}). Interestingly, under basal conditions, Flag-469 induced SG formation, even though it colocalized predominantly with p54 PBs. However, when cells were heat shocked at 42°C for 45 min, Flag-469 foci translocated to SGs ([Figure 5B](#F5){ref-type="fig"}). These data suggest that matr3 plays a role in SG induction from PBs and is capable of translocating to SGs during stress.

Next GST pull downs were performed with Matr3 GST-469, GST-322, and GST-RRM1 to determine which portion of the protein contained the relevant binding sites for PB protein complexes ([Figure 5C](#F5){ref-type="fig"}). Matr3 GST-469 pulled down endogenous Ago2 and p54 from U2OS cell extracts, while GST-322 or GST-RRM1 were unable to do so, suggesting that the PB-binding region requires both the ZnF1 and RRM1 domains ([Figure 5C](#F5){ref-type="fig"}).

As Flag-469 translocated from PBs to SGs under thermal shock, we examined whether Flag-469 interactions with PB proteins were disrupted after heat shock. Flag-469 co-IPs had less Ago2 and p54 after stress compared with control cells, suggesting Flag-469 binds to fewer PB proteins after heat shock ([Figure 5D](#F5){ref-type="fig"}). Together these experiments highlight a signicant portion of the matr3 protein that is required for PB and SG localization and interaction with PB proteins.

We then examined whether endogenous PB matr3 was capable of moving from PBs to stress granules. After heat shock, cells were costained with matr3 and Hedls or PABP-1 ([Figure 6](#F6){ref-type="fig"}). Interestingly, we observed a reduction in nuclear matr3 after heat shock. There was also a significant reduction in matr3 foci colocalizing with Hedls PBs, matching the data seen with Flag-469 and PBs following heat shock ([Figure 5B](#F5){ref-type="fig"}). Although matr3 foci did have greater Pearson's colocalization coefficient with PABP-1 after stress, only very weak colocalization was observed compared with the strong colocalization coefficient observed between Flag-469 and PABP-1 after stress ([Figures 6](#F6){ref-type="fig"} and [5B](#F5){ref-type="fig"}). Thus there are slight discrepancies between the behavior of endogenous matr3 and ectopic Flag-469, which are likely due to differing sequences of Flag-469 and endogenous matr3.

![After heat shock, endogenous matr3 does not colocalize with SGs; endogenous matr3 foci have reduced colocalization with Hedls PBs; and Matr3 foci have enhanced colocalization with PABP-1 after heat shock, even though the degree of colocalization remains weak. Furthermore, nuclear matr3 levels were reduced after heat shock. Colocalizations quantified using Pearson's colocalization coefficient (*N* = 15 over three experimental repeats). *\*\*\*\**, *p* \< 0.0001; Student's *t* test.](3894fig6){#F6}

Next we attempted to identify the origin of the truncated Matr3 PB variant by performing 5′ and 3′ rapid amplification of cDNA ends (RACE) on a HeLa cell cDNA library. However, no new sequences were amplified (unpublished data). Additionally, publicly available databases were screened for clones that could represent this isoform. However, this also failed to identify novel variants, suggesting that further investigation of matr3 sequences is required to identify this variant.

DISCUSSION
==========

Nesprins are a diverse family of intracellular scaffolds and linkers required for maintaining cellular organization and architecture through the generation of multiple isoforms. Here we identified several new nesprin-1 binding partners that provide further evidence that nesprin-1 is a versatile intracellular scaffold. Nesprin-1 scaffolding has already been shown to have an important role in PB function, and in this study, we identify matr3 as a new binding partner and define a previously unrecognized function for a well-studied nuclear protein in PB function.

Matr3 as a novel miRISC regulator, PB, and SG protein
-----------------------------------------------------

We identified matr3 as both a nesprin-1 binding partner and as a novel candidate for miRISC function, as demonstrated using the Let-7a and CXCR4 miRISC reporter constructs. Using an antibody raised against the N-terminus of matr3, we detected PB localization, which is consistent with the PB localization of nesprin-1 and its ability to interact with other PB proteins ([@B11]; [@B23]). Matr3 and DDx5 associated with the nesprin-1 SRs, which have previously been shown to interact with Ago2 and p54 and to be required for miRISC function. Although DDx5-depleted cells did not change Let-7a or CXCR4 miRSC activity, matr3 knockdown significantly attenuated miRISC function. The role matr3 plays in miRISC function has yet to be determined. Matr3 has previously been shown to bind small RNA, suggesting that it may be able to bind and sequester miRNAs from binding to mRNA targets ([@B27]). However, as matr3's interaction with Ago2 appears to be RNA dependent, it is likely to have a more direct role with the RISC complex.

As an antibody targeting the C-terminal end of Matr3 was unable to detect matr3 localization in PBs or coimmunoprecipitate with PB proteins, either a novel matr3 isoform or a cleavage product must reside within PBs. Indeed, by comparing nuclear and cytoplasmic fractions, we identified an ∼50 kDa cytosolic matr3 variant, and using co-IPs, we showed this variant interacts with PB proteins. Because matr3-containing PBs were depleted along with the 50 kDa Western band using siRNAs targeting the N-terminal region of the protein, but not the C-terminal region, at least two variants of matr3 exist, one that localizes to the nuclear matrix and another that localizes to PBs. As the C-terminal siRNA was unable to knockdown the 50 kDa Western band or PBs, the possibility of matr3 localizing to PBs as a result of a cleavage product of the larger nuclear protein is unlikely.

To identify the major domains required for matr3 PB localization, we created various C-terminal truncation constructs. Matr3-469, which terminates after the first RRM, encodes a 52 kDa construct that we show to localize within PBs. The degree of homology that exists between this construct and the actual ∼50 kDa matr3 isoform expressed in cells has yet to be determined. Interestingly, PB localization through truncation constructs suggests that RRM1 is necessary for localization, as its removal abolished cytoplasmic foci. Furthermore, the PB protein-binding sites on matr3 are likely to be located on both RRM1 and ZnF1, as the individual domains do not associate with PB proteins. Identifying which mRNA or miRNA transcripts bind with RRM1, along with any other protein-interacting partners that associate with the N-terminal portion of the protein, may help determine the role of matr3 in PBs.

The cytoplasmic foci formed by Flag-469 appeared to be a mixture of PBs and SGs at first glance. However, staining for endogenous PBs and SGs showed ectopic matr3-469 to predominantly localize in PBs, even though it was able to induce SG formation. These data indicate matr3 is important for SG formation from localizing to PBs, even though the mechanism of how it does this requires further work. Heat shock resulted in a stronger localization of matr3-469 in SGs, indicating it is also an SG protein, which is consistent with previous mass spectrometry data of SGs and overexpression studies showing matr3 in SGs ([@B10]; [@B13]). Furthermore, matr3 interactions with Ago2 and p54 were disrupted after heat shock, suggesting PB functions may be hampered after stress. Whether Flag-469 is able to translocate bound RNA species with it from PBs to SGs warrants further investigation. When we examined whether endogenous matr3 displayed similar effects after heat shock, we did see a reduction of matr3 with PBs and only a weak colocalization with SGs. The discrepancies between matr3-469 and endogenous matr3 are likely to be due to differences in sequences between the two forms. Interestingly, we did observe a significant reduction in endogenous nuclear matr3 levels after heat shock. Whether heat shock induces nuclear matr3 degradation or cytosolic translocation warrants further investigation. Also, whether a similar distribution is seen by Flag-469 and endogenous matr3 after other forms of stress are applied (e.g. oxidative stress by arsenite) is worth exploring.

Using 3′ RACE we attempted to identify a novel 3′ mRNA end but were unsuccessful, possibly due to several limitations associated with this approach, which include difficulty in amplifying rare or potentially long transcripts. Alternate matr3 variants were also not detected on exploration of publicly available databases, making the elucidation of the origin of this 50 kDa variant a focus of future studies.

The localization of our matr3 constructs did provide additional interesting findings about matr3. The nuclear localization signal (NLS) of matr3 has previously been shown to be located between residues 596 and 602, which makes the nuclear localization of Flag-567 interesting. Furthermore, a small population of Flag-469--transfected cells had weak nuclear localization, whereas Flag-322 was entirely cytoplasmic. These experiments suggest that there are at least two additional NLSs located within matr3; one between residues 470 and 567 and a weak NLS between residues 333 and 469.

Matr3 mutations have been identified in amyotrophic lateral sclerosis (ALS), and these mutations also map to the N-terminal region of matr3 that localizes to PBs and SGs. Although nuclear matr3 functions such as transcription and splicing could be disrupted as a result of ALS-causing mutations, there is a possibility that specific functions of PB matr3, such as miRISC function or SG-assembly properties, are also hampered. This is further supported by other RNA granule proteins, such as TDP-43 and FUS, also being mutated in ALS ([@B17]). Therefore further understanding of the role of matr3 in PB biology may provide useful insight into understanding the onset of ALS.

New novel functions for Nesprin-1
---------------------------------

Recently matr3 has been shown to interact with the C-terminal tail of lamin A/C, and this interaction is important in maintaining a correct interface between the lamina and nuclear matrix ([@B6]). Smaller KASH domain--containing isoforms of nesprin-1 also reside at the inner nuclear membrane and bind to lamin A/C. As nesprin-1 SRs share a high degree of homology, it is possible that SRs other than SR48 (SR1 in [Figure 1D](#F1){ref-type="fig"}) bind matr3. Thus it is likely that nesprin variants present within the LINC complex also form a scaffold with nuclear matr3, further suggesting that nuclear envelopathies due to nesprin and lamin mutations may also exhibit impaired connections with matr3. It is also plausible that many of the matr3 functions identified, including alternative splicing, DNA damage response, chromatin organization, and retention of hyperedited RNA, could be regulated by mechanical signals via the nesprins and the LINC complex ([@B19]; [@B35]; [@B28], [@B27]; [@B4]). This may be particularly important in the central nervous system and muscle, where nesprin (Emery-Dreifuss muscular dystrophy and autosomal-recessive cerebellar ataxia\]) and matr3 (ALS) mutations have been shown to induce disease ([@B34]; [@B14]).

We also identified other nesprin-1 binding partners involved in a variety of cellular activities, including transcription (DDx5, PSF), alternative splicing (PSF, DDx5, hnRNP A2/B1, Matr3), and DNA replication/damage repair (PCNA, Matr3) in this study ([@B8]; [@B9]; [@B2]; [@B4]). These findings illustrate the potential multifunctional nature of nesprin-1, wherein different isoforms generated through alternative transcription are likely to be involved in distinct biological roles. No nesprin-1 was detected by mass spectrometry in our screen, which initially suggests that these may not be novel nesprin-1 binding partners. However, we were able to show by Western blotting that nesprin-1 was indeed present within pAbN4 and pAbN5 immune complexes. There are several reasons for the absence of nesprin-1 as seen by mass spectrometry. One possibility is that the bands corresponding to nesprin-1 were not sufficiently excised or digested from the silver-stained gels. Another more likely scenario is that the binding partners associate with more than one SR within nesprin-1 or that multiple nesprin-1 isoforms have the same binding partners. As the central rod domain of nesprin-1 is present in a large number of isoforms, and as many SRs share a high homology, either case is possible and would result in a greater enrichment of binding partners relative to nesprin-1 proteins. Furthermore, we were able to map matr3 and DDx5 to specific SRs of nesprin-1 using GST pull downs, which strongly suggests that our screen did identify novel nesprin-1 binding partners. Identifying which proteins partner with the various nesprin-1 isoforms and the subcellular compartment in which these complexes localize will provide further insights into the importance of nesprin-1 variants as intracellular scaffolds and possible clues to how mutations in nesprin-1 may affect diverse signaling pathways in disease.

MATERIALS AND METHODS
=====================

Plasmids
--------

Matr3 C-terminal truncations mutants were created by introducing termination codons into pCI-Flag-Matrin3DNA3.1, which was kindly provided by Christopher Smith (University of Cambridge), using the QuikChange II site-directed mutagenesis kit (Agilent, Santa Clara, CA). Primers used for creating the truncations were as follows: Flag-798 (forward: 5′GACTATGTGATACCTAATAAAGGGTTTTACTGTAAG­CTG3′; reverse: 5′CAGCTTACAGTAAAACCCTTTATTAGGTATCACATAGTC3′), Flag-567 (forward: 5′GAGATGTGTGAAGG­TTGACTAGTCTGAGAAATATAAAAAACTG3′; reverse: 5′CAGTTT­TTTAT­ATTTCTCAGACTAGTCAACCTTCACACATCTC3′), Flag-469 (forward: 5′GCCAGTGAGAGTTCATTAATCCCAGAAGTATAAAA-GA3′; reverse: 5′ TCTTTTATACTTCTGGGATTAATGAACTCTCACT­GGC3′), Flag-322 (forward: 5′CGTCGATGCCAGCTTCTTTAAG­AAATCTA­CCCAGAATGG3′; reverse: 5′CCATTCTGGGTAGATTT­CTTAAAG­AAGCTGGCATCGACG3′). The psi-CHECK2-let-7 ×3 and psi-CHECK2-let-7 3× mut vectors were kindly provided by G. Hutvagner (University of Dundee, Scotland, UK; [@B15]). pRL-TK CXCR4 6× vector was kindly provided by P. Sharp (MIT; [@B7]) via Addgene.

Tissue culture
--------------

U2OS cells were passaged when reaching ∼70% confluency and maintained in DMEM complete (Sigma, St. Louis, MO) supplemented with 10 U/ml penicillin, 10 mg/ml streptomycin, 10 mg/ml glutamine, and 10% fetal bovine serum. When appropriate, cells were treated with sodium arsenite (0.5 mM), nocodazole (10 μg/ml), or cycloheximide (10 μg/ml) or in fresh culture media for 1 h.

Co-IPs
------

Cells were washed with phosphate-buffered saline (PBS), and extracts were prepared by scraping cells in ice-cold co-IP buffer (10 mM Tris, pH 7.4, 150 mM KCl, 1 mM ethylenediaminetetraacetic acid \[EDTA\], 1% Triton, and protease inhibitor cocktail). For identifying novel nesprin-1 binding partners using mass spectrometry, 250 mM KCl was used to increase stringency. Lysed cells were centrifuged at 13,050 × *g* for 20 min at 4°C and were precleared with protein A-- or protein G--Sepharose beads (Sigma) for 1 h at 4°C with rotation. Protein complexes were obtained by incubating 2 μg of relevant antibody with 200 μg of cell lysate overnight at 4°C with gentle rotation. Immune complexes were purified using Sepharose beads, washed three times with co-IP buffer, and boiled in loading buffer, and then the entire co-IP was analyzed by Western blotting or silver staining.

The co-IPs for the RNase treatment were performed under identical conditions. However, washed beads were resuspended into co-IP buffer and divided into two equal volumes. RNase mixture (10 μg/ml; DNase free; Roche, Basel, Switzerland) was added to one, and both were incubated at room temperature (RT) for 20 min. After two washes in cold co-IP buffer, proteins were eluted in loading buffer.

GST pull down
-------------

GST and GST fusion proteins were induced from 100 ml of bacterial culture for 2 h using 0.2 mM isopropyl β-[d]{.smallcaps}-1-thiogalactopyranoside at 30°C. Ten to twenty microliters of culture was used for purification (the rest was pelleted and frozen) according to the GE Healthcare protocol using glutathione--Sepharose 4B beads (GE Healthcare, Little Chalfont, United Kingdom). Pull downs were performed from U2OS whole-cell lysates prepared as described above. Four hundred micrograms of protein lysates was incubated with 30 μl beads overnight at 4°C with rotation. Bound proteins were eluted into protein loading buffer, and the entire pull down was analyzed by Western blotting.

Mass spectrometry
-----------------

Bands from silver-stained gels were excised and cut into small pieces of ∼2 mm using a sterile scalpel. In-gel digestion was performed with trypsin on a robotic digestion system (Investigator ProGest; GENOMIC SOLUTIONS, Ann Arbor, MI). Peptides were separated by a nanoflow liquid-chromatography (LC) system on a reverse-phase column (C18 PepMap100, 3 μm, 100 Å, 25 cm; Dionex) and subjected to tandem mass spectrometry (MS/MS) analysis (LTQ-Orbitrap XL, Thermo Fisher Scientific). The spectra were matched against the human database (UniProtKB/Swiss-Prot Release 14.6, 20,333 protein entries). Protein hits with identification probability \> 99.0% and at least two unique peptides with identification probability \> 95% were selected using Scaffold software (version 2.0; Proteome Software, Portland, OR) and considered for further work. Mass spectrometry was performed by Xiaoke Yin (King's College London).

Cytoplasmic and nuclear fractionations
--------------------------------------

Plated cells were washed twice with PBS and harvested by scraping cells in an appropriate volume of nuclear fractionation buffer (250 mM sucrose, 20 mM HEPES, pH 7.4, 10 mM KCl, 1.5 mM MgCl~2~, 1 mM EDTA, 1 mM dithiothreitol, and protease inhibitor cocktail). The cells were collected and incubated on ice for 10 min; this was followed by a centrifugation at 845 × *g* for 10 min in a 4°C centrifuge to pellet nuclei. The supernatant containing the cytoplasmic fraction was transferred to a fresh Eppendorf. The pelleted nuclei were resuspended in an appropriate volume of RIPA buffer (150 mM KCl, 1% NP-40, 0.1% SDS, 0.5% sodium deoxycholate, and protease inhibitor cocktail), vortexed, incubated on ice for 10 min, and centrifuged at 13,050 × *g* for 10 min in a 4°C centrifuge. The supernatant was collected as the nuclear fraction, and 10--20 μg of protein per fraction was analyzed by Western blotting.

Western blotting
----------------

Cell extracts were resolved on a 10% SDS--PAGE gel and transferred to polyvinylidene fluoride membrane (Millipore, San Diego, CA) using a semidry apparatus. The membranes were blotted with the antibodies indicated in each figure, and bands were visualized using the ECL Western blotting substrate (Thermo Fisher Scientific, Waltham, MA). Membranes were incubated with the following primary antibodies: anti-Rck/p54 (ab54611; Abcam, Cambridge, United Kingdom), anti-Ago2 (ab57113; Abcam), anti-Dcp1a (ab57654; Abcam), anti--β-actin (A2228; Sigma), anti-Matr3C (ab84422; Abcam), anti-Matr3N (ab51081; Abcam), PSF (sc-101137; Santa Cruz, Santa Cruz, CA), DDx5 (ab21696; Abcam), Importin-β (ab2811; Abcam) mouse anti--α-tubulin (T5168; Sigma-Aldrich), rabbit-LaminB1 (sc-20682; Santa Cruz). Secondary antibodies conjugated to horseradish peroxidase (GE Healthcare) were used at 1:10,000 dilutions and developed using ECL reagent and X-ray film. Densitometry measurements were performed using ImageJ.

Let-7 miRISC luciferase assay
-----------------------------

Twelve thousand U2OS cells were plated into each well of a 24-well plate and cultured under standard growth conditions overnight. The following day, three wells per experimental condition were cotransfected with 1 μl Matr3, DDx5, Rck/p54, or scrambled siRNA oligos (all at 20-μM stock solutions) and 1 μg of psi-CHECK2-let-7 ×3 or psi-CHECK2-let-7 ×3 m using Hiperfect transfection reagent (Qiagen). siMatr3 and si-DDx5 si-p54 sequences used were 5′GUCAUUCCAGCAGUCAUCUUU3′ and 5′AAGAGGUGGAAACAUACAGAA3′, respectively. Si-p54 was a Smart pool obtained from Dharmacon (L-006371-00-000). Luciferase readings were taken 72 h after transfection using the Dual-Luciferase Reporter assay (Promega, Madison, WI). *Renilla* luciferase activity was normalized to firefly luciferase activity to control for transfection efficiency (both transcribed off the psi-CHECK2 plasmids).

CXCR4 miRISC luciferase assay
-----------------------------

Twelve thousand U2OS cells were plated into each well of a 24-well plate and cultured under standard growth conditions overnight. The following day, three wells per experimental condition were transfected with Hiperfect siRNA-plasmid complexes containing 1 μg pRL-TK CXCR4 6× Renilla luciferase plasmids, 50 ng pGL3.4 firefly luciferase plasmid, 1 μl CXCR4 siRNA oligo (20 μM stock), and 1 μl of siRNA oligo (20 μM stock) targeting proteins to be knocked down. Luciferase readings were taken 72 h after transfection using the Dual-Luciferase Reporter assay (Promega). *Renilla* luciferase activity was normalized to firefly luciferase activity to control for transfection efficiency.

siRNA-mediated gene silencing
-----------------------------

Sixty thousand U2OS cells were plated into each well of a six-well plate and cultured under standard growth conditions overnight. The following day, cells were transfected with 1 μl siM3N, siM3C or scrambled siRNA oligos (all at 20-μM stock solutions) using Hiperfect transfection reagent (Qiagen, Hilden, Germany). siM3N and siM3C were 5′GUCAUUCCAGCAGUCAUCUUU3′ and 5′GCUCCUCCAA­GUAGCAAUAUU3′, respectively. Knockdown efficiency was analyzed using 10--20 μg of cell extract by Western blotting.

Immunofluorescence microscopy
-----------------------------

Cells were fixed for 5 min in 3.7% paraformaldehyde (PFA) (Sigma-Aldrich) followed by 2 min permeabilization with 0.5% NP-40 (EMD Millipore). The coverslips were incubated with blocking solution (1% bovine serum albumin) for 1 h at RT. Primary antibodies used for immune staining were diluted in blocking solution and applied to the coverslips for 1 h at RT; this was followed by three short rinses in PBS. Primary antibodies were as follows: anti-Matr3C (ab84422; Abcam), anti-Matr3N (ab51081; Abcam), and mouse anti-S6K used to detected Hedls (sc-8418; Santa Cruz) at 1:200; rabbit anti-Rck/p54 (A300-461A; Bethyl Laboratories, Montgomery, TX) and mouse anti-PABP-1 (10E10, sc-32318; Santa Cruz) at 1:200. Next the coverslips were incubated with secondary antibodies, diluted 1:1000 in blocking buffer, and conjugated to Alexa Fluor 405, 488, or 546 (Invitrogen, Carlsbad, CA) for 1 h at RT. The coverslips were next stained with 4′,6-diamidino-2-phenylindole and rinsed with PBS before being mounted onto slides using Mowiol mounting media. Images were acquired at RT using a using an Olympus IX81 wide-field microscope with a 40× air objective lens attached to a Hamamatsu Orca-R2 cooled CCD camera. Pearson's colocalization coefficients were determined using the Coloc2 plug-in in imageJ.

This article was published online ahead of print in MBoC in Press (<http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E16-06-0346>) on October 12, 2016.
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Ago2

:   Argonaute-2

ALS

:   amyotrophic lateral sclerosis

co-IP

:   coimmunoprecipitation

GST

:   glutathione *S*-transferase

IgG

:   immunoglobulin G

LINC

:   linker of the nucleoskeleton and cytoskeleton

Matr3

:   matrin-3

miRISC

:   miRNA-mediated gene silencing

NE

:   nuclear envelope

NLS

:   nuclear localization signal

PB

:   processing body

PBS

:   phosphate-buffered saline

PSF

:   PTB-associated splicing factor

RRM

:   RNA-recognition motif

RT

:   room temperature

SG

:   stress granule

siRNA

:   small interfering RNA

SR

:   spectrin repeat

ZnF

:   zinc finger.
